Erratum to: “Cutaneous T‐Cell Lymphomas: 2023 Update on Diagnosis, Risk‐Stratification, and Management”

In the manuscript, on Page 196, Lines 33-37, it is remarked that "recent consensus recommendations support of the use of peripheral blood flow cytometry in specific patient groups: those with advanced stage ( IIB) disease, intractable pruritis, generalize patches/ plaques, erythroderma, lymphocytosis, an elevated LDH, or a lack of response to skin-directed therapies."However, upon review of the primary research (Citation 81) this line references, it appears this statement is misleading.In the article referenced, Vermeer